Repligen Corp (RGEN)
142.58
+0.82
(+0.58%)
USD |
NASDAQ |
Nov 22, 16:00
142.62
+0.04
(+0.03%)
After-Hours: 20:00
Repligen Free Cash Flow: 131.26M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 131.26M |
| June 30, 2024 | 119.26M |
| March 31, 2024 | 109.54M |
| December 31, 2023 | 74.93M |
| September 30, 2023 | 97.48M |
| June 30, 2023 | 51.15M |
| March 31, 2023 | 45.58M |
| December 31, 2022 | 38.74M |
| September 30, 2022 | 14.50M |
| June 30, 2022 | 41.48M |
| March 31, 2022 | 42.43M |
| December 31, 2021 | 47.74M |
| September 30, 2021 | 34.66M |
| June 30, 2021 | 40.18M |
| March 31, 2021 | 31.98M |
| December 31, 2020 | 36.28M |
| September 30, 2020 | 43.66M |
| June 30, 2020 | 42.36M |
| March 31, 2020 | 42.60M |
| December 31, 2019 | 44.06M |
| September 30, 2019 | 33.60M |
| June 30, 2019 | 34.06M |
| March 31, 2019 | 24.68M |
| December 31, 2018 | 18.73M |
| September 30, 2018 | 32.08M |
| Date | Value |
|---|---|
| June 30, 2018 | 13.84M |
| March 31, 2018 | 12.15M |
| December 31, 2017 | 12.00M |
| September 30, 2017 | -0.362M |
| June 30, 2017 | -0.866M |
| March 31, 2017 | 7.29M |
| December 31, 2016 | 3.196M |
| September 30, 2016 | 4.884M |
| June 30, 2016 | 14.40M |
| March 31, 2016 | 11.76M |
| December 31, 2015 | 12.42M |
| September 30, 2015 | 8.761M |
| June 30, 2015 | 7.079M |
| March 31, 2015 | 1.82M |
| December 31, 2014 | 12.80M |
| September 30, 2014 | 19.79M |
| June 30, 2014 | 19.11M |
| March 31, 2014 | 25.42M |
| December 31, 2013 | 21.30M |
| September 30, 2013 | 21.98M |
| June 30, 2013 | 20.24M |
| March 31, 2013 | 13.87M |
| December 31, 2012 | 12.18M |
| September 30, 2012 | 5.363M |
| June 30, 2012 | 0.3242M |
Free Cash Flow Range, Past 5 Years
14.50M
Minimum
Sep 2022
131.26M
Maximum
Sep 2024
56.49M
Average
43.13M
Median
Free Cash Flow Benchmarks
| West Pharmaceutical Services Inc | 321.60M |
| QuidelOrtho Corp | -96.80M |
| Perspective Therapeutics Inc | -40.58M |
| Xtant Medical Holdings Inc | -17.28M |
| Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 49.32M |
| Cash from Investing (Quarterly) | -5.859M |
| Cash from Financing (Quarterly) | -69.60M |
| Free Cash Flow Per Share (Quarterly) | 0.7531 |
| Free Cash Flow to Equity (Quarterly) | 107.78M |
| Free Cash Flow to Firm (Quarterly) | 45.34M |
| Free Cash Flow Yield | 1.64% |